Statement regarding costs of buprenorphine
Around the beginning of May 2018 Delphi Medical were made aware of the potential risk of cost increases in buprenorphine secondary to the implementation of a central pricing control mechanism. The most important issue from a Delphi Medical point of view is to ensure that our patients receiving buprenorphine have continuity of care as part … Continued